Page 60 - 17AIS Program Book

Novabind PowerPollen, LLC
Showcase Companies

NovoBind Livestock Therapeutics is PowerPollen , LLC is transforming
TM
an agri-biotech company developing how plants cross-pollinate. Cross-
cost-effective feed additives that pollination is the enabler for the
function as alternatives to antibiotics. production of hybrid crops, which are
Our products specifically target and many-fold times more productive than
neutralize specific pathogens like non-hybrid crops. However, ensuring
Salmonella, from livestock. cross-pollination is very expensive and
in many crops it is cost-prohibitive.
The global loss to the food and poultry Two years of field testing in corn has
industry due to Salmonella, Necrotic resulted in an unprecedented scaled
Enteritis (Clostridium Perfringens) and pollen handling and preservation
Coccidiosis (Eimeria) is estimated to be technology that decreases the cost of
as high as $15B a year. producing hybrid seed and increases
yield. Commercialization in corn will
Our multidisciplinary team of generate significant revenues in 2018.
biochemists, microbiologists, and PowerPollen technology will enable
TM
veterinary pathologists work closely hybridity in crops like wheat, which is
with our experienced management a key to ensuring future global food
team and extended advisory security and improving farmer profits.
committees to execute a global
strategy. PRESENTER:

Our vision is to become the global Todd Krone
leader in targeted antimicrobials using CEO
next generation antibody fragments. (515) 229-0961
powerpollen.com
PRESENTER: (website not active yet)

Hamlet Abnousi
Co-founder & CEO
hamlet@novobind.com
(604) 218-4594

56 #17AIS Ag Innovation Showcase